Form 4: Madrigal Pharma Director Exercises Stock Options

Madrigal Pharmaceuticals director Richard S. Levy exercised 4,000 stock options at $16.46 per share, increasing his direct common stock holdings to 25,197 shares.

Summary

• Richard S. Levy, a Director of Madrigal Pharmaceuticals, Inc. (MDGL), executed a transaction on January 26, 2026.
• The transaction involved the exercise of 4,000 stock options at an exercise price of $16.46 per share.
• As a result of the option exercise, 4,000 shares of Common Stock were acquired directly.
• Following this transaction, Mr. Levy directly beneficially owns 25,197 shares of Common Stock.
• The stock options exercised were fully vested and exercisable, with an expiration date of June 29, 2027.
• This transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive due to a director increasing their direct ownership, which can be interpreted as a sign of confidence. However, it's an option exercise, which is often a routine event for insiders, and not a direct open-market purchase.

Positives

• Director Richard S. Levy increased his direct beneficial ownership of Madrigal Pharmaceuticals common stock by 4,000 shares, potentially signaling confidence in the company's future.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned and systematic approach to insider trading, which can reduce concerns about opportunistic timing.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is a routine disclosure for a publicly traded biotechnology company. It reflects a director's personal equity management rather than a broader industry trend or strategic move by Madrigal Pharmaceuticals.

Related Party Transactions

• Director Richard S. Levy's exercise of stock options and subsequent acquisition of common stock constitutes an insider transaction, which is a form of related party dealing.

Stakeholder Impact

• Shareholders may view the increased direct ownership by a director as a positive signal of management's alignment with shareholder interests and confidence in the company's prospects.

Key Dates

Recommendation

The exercise of 4,000 stock options by a director, while a positive signal of confidence, is a relatively small transaction in the context of a public company and was executed under a pre-arranged 10b5-1 plan. It does not provide sufficient new information to warrant a change in investment recommendation, thus a 'hold' stance is appropriate, acknowledging the minor positive without suggesting a significant catalyst.

Keywords

Madrigal Pharmaceuticals, MDGL, Richard S. Levy, Insider Transaction, Stock Option Exercise, Director, Form 4, Equity Compensation